Daiichi Sankyo company Ltd is Trading in All-Time High. The Market is Approaching the Trendline, so Next Target is Trendline Top and Chance to Make a +42% PROFIT. Support me; I want to Help People Make PROFIT all over the "World".
Johnson & Johnson (JNJ) quickly hit the $147.00 Target that we set on our very recent sell call (April 03, see chart below) and is now approaching the bottom of the massive 2-year Channel Down: Even though based on the very reliable and consistent Sine Waves, the bottom might be a process that can take up to 2-months, the stock is low enough for medium-term...
Introduction: In the ever-evolving landscape of biopharmaceuticals, Connect Biopharma Holdings Limited (NASDAQ: CNTB) emerges as a beacon of potential, navigating through the complexities of drug development with promising advancements and strategic maneuvers. This analysis dives into the core of CNTB's recent activities, financial health, and future prospects,...
Hologic is currently Consolidating within the potential handle of a Bullish Cup with Handle pattern and is holding above the 200-week Simple Moving Average. If this pattern plays out successfully, the measured move target would take HOLX up to around $118. n addition to the technical pattern, HOLX seems to be improving its balance sheet on an annual basis,...
Ive been eyeing TDOC for some time, finally posting a chart on it talking about TA developments that may indicate a potential bottom area earlier this week (Check below for the link to that chart). I was also in the camp of TDOC going lower to the low $20 or high Teens ($18-19). This weeks move of 30%, closing the weekly candle at 20% gains was a wonderful...
Hello. This chart is strictly a Technical Analysis of Teladoc (TDOC). I think currently we are in a point in TDOC's price action where we've reached a fundamental SUPPORT area if you look back to 2016. This could potentially be opportune BUY ZONE. TA is all about probability. The probability we go down is always there, just in this scenario i believe the...
Revance Therapeutics, Inc.( NASDAQ:RVNC ) Sector: Health Technology (Pharmaceuticals: Major) Market Capitalization: $2.124B Current Price: $29.17 Breakout price: $30.00 Buy Zone (Top/Bottom Range): $27.45-$24.15 Price Target: $41.10-$42.00 Estimated Duration to Target: 132-142d Contract of Interest: $RVNC 1/20/23 30c Trade price as of publish date: $3.70/contract
This is a daily chart of Veeva Systems (VEEV), a healthcare technology company that provides cloud solutions for the global life sciences industry. When the company reported its earnings on August 31st the stock price subsequently gapped down, as shown in the chart above. From a probability standpoint, this gap is likely to be filled for the reasons below. 1....
I rarely dabble in health service companies. But, after doing some reading I see a lot of merit in their mission, and this company could easily be worth 10X its current market capitalization if utilized by the Health service industry or acquired by an insurers to cut liability costs. Little can be distilled from available chart data, and comprehending the...
Bat harmonic pattern targets: AB=0.38 XA BC=0.38 AB tp1=1.6 BC=$9 tp2=2.6 BC=$25 tp3=0.88 XA=$68 Crab harmonic pattern targets: tp1=2.6 BC=$25 tp2=3.6 BC=$68 tp3=1.6 XA=$3385
Day Traders Lighting Up Reddit Spur Rally in Tiny Health Stock Zomedica Such outsized moves in small-caps are becoming par for the course these days. Surging at the open on the back of mentions in Reddit forums was Zomedica Corp., a company that develops medicines for pets. The stock jumped as much as 98% on Monday and is up almost four-fold from the start or...
Consolidating above VPOC with fib targets above.